Journal of Membrane Science & Technology

Implication of G Protein-Coupled Receptors in Cellular Processes and Drug Development

William Kobilka^* Department of Structural Biology, Stanford University School of Medicine, California, USA
^*Correspondence: William Kobilka, Department of Structural Biology, Stanford University School of Medicine, California, USA, Email:

Received: 23-Jun-2023, Manuscript No. JMST-23-22526; Editor assigned: 26-Jun-2023, Pre QC No. JMST-23-22526 (PQ); Reviewed: 10-Jul-2023, QC No. JMST-23-22526; Revised: 17-Jul-2023, Manuscript No. JMST-23-22526 (R); Published: 24-Jul-2023, DOI: 10.35248/2155-9589.23.13.357

Description

G Protein-Coupled Receptors (GPCRs) are a class of proteins that are essential for a variety of cellular processes. They act as signaling molecules that transmit signals from outside the cell to the inside, regulating gene expression, cell metabolism, and other physiological functions. GPCRs are also important drug targets because they can be activated or inhibited by specific drugs. In this article, we will discuss how GPCRs work, why they are important drug targets, and how they can be used in drug development [1,2].

GPCRs, or G protein-coupled receptors, are cell membrane proteins that are used by cells to detect and respond to various external signals. GPCRs contain seven trans-membrane structures and a binding site that can recognize and bind with specific molecules. When this binding occurs, the GPCR undergoes a conformational change, allowing it to interact with other molecules and initiate a cascade of events. GPCRs are found in all organisms, from bacteria to humans. In humans, they are involved in numerous physiological processes such as cell-cell communication, sensory perception, endocrine regulation, and more [3-5].

GPCRs work by detecting and responding to specific molecules in their environment. When a molecule binds to the GPCR, the receptor undergoes a conformational change, allowing it to interact with other molecules and initiate a cascade of events. This cascade of events ultimately leads to changes in the cell, such as the release of hormones or the activation of proteins. GPCRs play an important role in cell-cell communication. They allow cells to detect and respond to external signals and enable cells to communicate with each other in a coordinated manner [6,7].

GPCRs are constructed from seven trans-membrane helices, which are arranged in a specific pattern. The helices create a binding pocket on the outside of the cell, which is used to bind to specific molecules. The helices are connected by three intracellular loops, which interact with G proteins. G proteinsare proteins that are involved in signal transduction. When a GPCR binds to a molecule, the G protein is activated, initiating a cascade of events. Some GPCRs are dependent on lipids for their function. These GPCRs require the presence of specific lipids in their environment in order to be activated. For example, the rhodopsin GPCR requires the presence of phospholipids and cholesterol in order to function [8,9].

GPCRs are important drug targets because they can be activated or inhibited by specific drugs. By blocking or activating specific GPCRs, drugs can alter the signaling pathways inside the cell, resulting in the regulation of various physiological processes. This makes GPCRs attractive targets for the development of drugs that can be used to treat a wide variety of conditions, such as hypertension, diabetes, and more. GPCRs can be used in drug development in two ways. First, drugs can be developed to specifically target and activate or inhibit specific GPCRs. This approach is used in the development of drugs that target GPCRs to treat diseases such as hypertension, depression, and cancer. Second, GPCRs can be used to screen for new drug candidates. This approach involves testing potential drug candidates on GPCRs to see if they can effectively activate or inhibit the GPCRs. This is a useful tool for drug discovery, as it allows researchers to quickly identify potential drugs that could be used to treat a variety of diseases [10].

Conclusion

GPCRs are an important class of receptors that are involved in a variety of physiological processes. They are also important drug targets, as many drugs act through binding to GPCR molecules. GPCRs are constructed from seven trans-membrane helices, which are connected by three intracellular loops. Some GPCRs are dependent on lipids for their function, and they can be used to treat a variety of conditions.

References

1. Rosenbaum DM, Rasmussen SG, Kobilka BK. The structure and function of G-protein-coupled receptors. Nature. 2009;459(7245):356-363.

   [Crossref] [Google Scholar] [PubMed]

2. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer. 2007;7(2):79-94.

   [Crossref] [Google Scholar] [PubMed]

3. Strader CD, Fong TM, Tota MR, Underwood D, Dixon RA. Structure and function of G protein-coupled receptors. Annual Rev Biochem. 1994;63(1):101-132.

   [Crossref] [Google Scholar] [PubMed]

4. Venkatakrishnan AJ, Deupi X, Lebon G, Tate CG, Schertler GF, Babu MM. Molecular signatures of G-protein-coupled receptors. Nature. 2013;494(7436):185-194.

   [Crossref] [Google Scholar] [PubMed]

5. Kroeze WK, Sheffler DJ, Roth BL. G-protein-coupled receptors at a glance. J Cell Sci. 2003;116(24):4867-4869.

   [Crossref] [Google Scholar] [PubMed]

6. Kolakowski Jr LF. GCRDb: A G-protein-coupled receptor database. Recept Channels. 1994;2(1):1-7.

   [Google Scholar] [PubMed]

7. Strader CD, Fong TM, Grazlano MP, Tota MR. The family of G-protein-coupled receptors. FASEB J. 1995;9(9):745-754.

   [Crossref] [Google Scholar] [PubMed]

8. Oldham WM, Hamm HE. Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol. 2008;9(1):60-71.

   [Crossref] [Google Scholar] [PubMed]

9. Chou KC, Elrod DW. Bioinformatical analysis of G-protein-coupled receptors. J Proteome Res. 2002;1(5):429-433.

   [Crossref] [Google Scholar] [PubMed]

10. Horn F, Bettler E, Oliveira L, Campagne F, Cohen FE, Vriend G. GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res. 2003;31(1):294-297.

    [Crossref] [Google Scholar] [PubMed]